A New Haven-based biotech company has developed advanced technology that uses gene-editing to improve the quality of lettuce.

According to a comprehensive market research report titled "Metagenomics Market Size, Share, Forecast, & Trends Analysis by ...

TORONTO, May 30, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and ...

An Eikon Therapeutics logo is visible on a building in Hayward, Calif., in July 2022. The company now does business out of a Millbrae facility, where it’s cutting staff.

TARRYTOWN, N.Y. (AP) — Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.

Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing company running without interruption and uphold its privacy-protection ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.